Abstract Objectives The objective of this study is to find clinical variables that predict the prognosis for men with castration‐resistant prostate cancer (CRPC) in a Swedish real‐life CRPC cohort, including a risk group classification to clarify the risk of succumbing to prostate cancer. This is a natural history cohort representing the premodern drug era before…
BJUI Compass Template
Write in a clean editor, then format for BJUI Compass in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the BJUI Compass format
BJUI Compass is a peer-reviewed journal published by Wiley, covering Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." BJUI Compass 12 (3): 45–58.
Formats any DOI in BJUI Compass style. No sign-up. |
| Publishes research in | Prostate Cancer Diagnosis and Treatment Bladder and Urothelial Cancer Treatments Prostate Cancer Treatment and Research Urinary Bladder and Prostate Research Kidney Stones and Urolithiasis Treatments |
| ISSN | 2688-4526 |
| Citation impact (2-yr) | 1.42 |
| h-index | 23 |
| i10-index | 106 |
| Total citations | 3,096 |
| Article processing charge | $2,400 |
| Open access | Yes |
| Top institutions publishing here | University College London |
| Journal website | bjui-journals.onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in BJUI Compass per year
Citation impact of BJUI Compass by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in BJUI Compass
Abstract Objective The aim of this study is to report the updated 2‐year results of the intervention arm of the ROBUST III randomized trial evaluating the safety and efficacy of the Optilume drug‐coated balloon (DCB) versus standard endoscopic management of recurrent male anterior urethral stricture. Materials and Methods Eligible patients included men with recurrent anterior…
Introduction: The coming decade will see the emergence of many surgical robotic systems that need to prove their cost-effectiveness and clinical usability to gain the trust of robotic surgeons worldwide. Herein, we provide a concise review of the currently available robotic systems. Since the da Vinci Surgical System's patent expired and its market monopoly ended,…
Objective: The objective of this study is to determine if Aquablation therapy can maintain its effectiveness in treating men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) with large-volume (80-150 cc) prostates at 3 years. Subjects and Methods: One hundred one men with moderate-to-severe BPH symptoms and prostate volumes between 80…
Abstract Objectives To study high‐frequency 29 MHz transrectal side‐fire micro‐ultrasound (micro‐US) for the detection of clinically significant prostate cancer (csPCa) on prostate biopsy, and validate an image interpretation protocol for micro‐US imaging of the prostate. Materials and methods A prospective randomized clinical trial was performed where 1676 men with indications for prostate biopsy and without…